Evidence map›Paper›PMID 24714513›Full record

ArticleAmerican journal of nephrology2014

Chronic kidney disease in an electronic health record problem list: quality of care, ESRD, and mortality.

Stacey E Jolly, Sankar D Navaneethan, Jesse D Schold, Susana Arrigain, John W Sharp, Anil K Jain, Martin J Schreiber, James F Simon, Joseph V Nally

Abstract read
In one paragraph

Article in American journal of nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025
    Article
  5. Review
  6. Impact of electronic medical record utilization on obesity screening and intervention for obese patients with endometrial cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2024
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stacey E JollyDepartment of General Internal Medicine, Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sankar D Navaneethan
Jesse D Schold
Susana Arrigain
John W Sharp
Anil K Jain
Martin J Schreiber
James F Simon
Joseph V Nally

Funding

Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
Case Western Reserve University/Cleveland Clinic CTSA (KL2)KL2RR024990 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$9.5M
Chronic Kidney Disease Knowledge and Awareness among American IndiansK23DK091363 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI JOLLY, STACEY · 2011 to 2015
$796k
Navigating the Challenges of Chronic Kidney DiseaseR34DK094112 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI NALLY, JOSEPH · 2011 to 2013
$700k
NCATS NIH HHS KL2 TR000440NCRR NIH HHS KL2 RR024990NCRR NIH HHS RR024990NIDDK NIH HHS 1K23DK091363NIDDK NIH HHS K23 DK091363NIDDK NIH HHS R34 DK094112NIDDK NIH HHS R34DK094112
6 · The paper itself

Abstract

backgroundWhether chronic kidney disease (CKD) recognition in an electronic health record (EHR) problem list improves processes of care or clinical outcomes of end-stage renal disease (ESRD) and death is unclear.

methodsWe identified patients who had at least 1 year of follow-up (2005-2009) in our EHR-based CKD registry (n = 25,742). CKD recognition was defined by having ICD-9 codes for CKD, diabetic kidney disease, or hypertensive kidney disease in the problem list. We calculated proportions of patients with and without CKD recognition and examined differences by demographics, clinical factors, and development of ESRD or mortality. We evaluated differences in the proportion of patients with CKD-specific laboratory results checked before and after recognition among cases and propensity-matched controls.

resultsOnly 11% (n = 2,735) had CKD recognition in the problem list and they were younger (68 vs. 71 years), a higher proportion were male (61 vs. 37%) and African-American (21 vs. 10%) compared to those unrecognized. CKD-specific laboratory results for patients with estimated glomerular filtration rate (eGFR) 30-59 including intact parathyroid hormone (23 vs. 6%), vitamin D (22 vs. 18%), phosphorus (29 vs. 7%), and a urine check for proteinuria (55 vs. 36%) were significantly more likely to be done among those with CKD recognition (all p < 0.05). Similar results were found for eGFR <30 except for proteinuria and in our propensity score-matched control analysis. There was no independent association of CKD recognition with ESRD or mortality.

conclusionsCKD recognition in the EHR problem list was low, but translated into more CKD-specific processes of care; however ESRD or mortality were not affected.

Indexed as

AgedAged, 80 and overElectronic Health RecordsFemaleHumansMaleMiddle AgedOhioPropensity ScoreQuality of Health CareRenal Insufficiency, Chronic

Identifiers

PMID24714513
PMCPMC4056768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.